Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ
Open Access
- 1 October 2006
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 192 (4) , 520-524
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Magnetic Resonance Imaging Captures the Biology of Ductal Carcinoma In SituJournal of Clinical Oncology, 2006
- Nonpalpable Mammographically Occult Invasive Breast Cancers Detected by MRIAmerican Journal of Roentgenology, 2006
- Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imagingThe Breast, 2006
- The Impact of MRI on the Treatment of DCISThe American Surgeon™, 2005
- Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease?Magnetic Resonance Imaging, 2005
- Benign Breast Disease and the Risk of Breast CancerNew England Journal of Medicine, 2005
- MRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemotherapy and Recurrence-Free SurvivalAmerican Journal of Roentgenology, 2005
- Neoadjuvant hormonal therapy for ductal carcinoma in situ: Trial design and preliminary resultsAnnals of Surgical Oncology, 2004
- Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and MulticentricityAnnals of Surgical Oncology, 2003
- Contrast‐Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast CarcinomaThe Breast Journal, 1999